{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:32:51Z","timestamp":1759411971468,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.041","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T08:49:22Z","timestamp":1578646162000},"page":"1593-1596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule"],"prefix":"10.1016","volume":"38","author":[{"given":"Inbal","family":"Galor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Perry Markovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meital","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hartal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Avramovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.12.041_b0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis a in Israel following universal immunization of toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.12.041_b0010","doi-asserted-by":"crossref","first-page":"21040","DOI":"10.2807\/1560-7917.ES2015.20.7.21040","article-title":"The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012","volume":"20","author":"Levine","year":"2015","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2019.12.041_b0015","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/j.vaccine.2006.03.010","article-title":"Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines","volume":"24","author":"Orr","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.041_b0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0950268898001198","article-title":"Hepatitis A antibody prevalence among young adults in Israel \u2013 the decline continues","volume":"121","author":"Gdalevich","year":"1998","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.12.041_b0025","first-page":"5","article-title":"Epidemiology of Hepatitis A in the Israeli defense forces, 1970\u20132010","volume":"2","author":"Zahavi","year":"2012","journal-title":"J Isr Mil Med"},{"key":"10.1016\/j.vaccine.2019.12.041_b0030","unstructured":"DiaSorin S.p.A. Hepatitis and retrovirus Hepatitis A and B from challenges to solutions. n.d."},{"key":"10.1016\/j.vaccine.2019.12.041_b0035","unstructured":"Central Bureau of Statistics. Statistical abstract of Israel 2018; 2019."},{"key":"10.1016\/j.vaccine.2019.12.041_b0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","article-title":"Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention","volume":"68","author":"Lemon","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2019.12.041_b0045","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1097\/INF.0000000000001640","article-title":"Seroprevalence of Hepatitis A twelve years after the implementation of toddlers\u2019 vaccination: a population-based study in Israel","volume":"36","author":"Bassal","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.041_b0050","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/21645515.2016.1242539","article-title":"Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines \u2013 A systematic review","volume":"13","author":"Stuurman","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.12.041_b0055","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/INF.0000000000001322","article-title":"Single-dose universal Hepatitis A immunization in one-year-old children in Argentina","volume":"35","author":"Urue\u00f1a","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.041_b0060","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1097\/INF.0000000000001176","article-title":"Long-term serologic follow-up of children vaccinated with a pediatric formulation of virosomal Hepatitis A vaccine administered with routine childhood vaccines at 12\u201315 months of age","volume":"35","author":"Dagan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.041_b0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/INF.0000000000000605","article-title":"Modeling the long-term persistence of hepatitis a antibody after a two-dose vaccination schedule in Argentinean children","volume":"34","author":"L\u00f3pez","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.041_b0070","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/INF.0000000000001322","article-title":"Single-dose universal hepatitis a immunization in one-year-old children in Argentina: High prevalence of protective antibodies up to 9 years after vaccination","volume":"35","author":"Urue\u00f1a","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.041_b0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13557858.2015.1068281","article-title":"Ethnicity and immunization coverage among schools in Israel","volume":"21","author":"Yitshak-Sade","year":"2016","journal-title":"Ethn Heal"},{"key":"10.1016\/j.vaccine.2019.12.041_b0080","first-page":"630","article-title":"The effects of socioeconomic factors on the decision to be vaccinated: The case of flu shot vaccination","volume":"8","author":"Shahrabani","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2019.12.041_b0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","article-title":"Sex differences in vaccine-induced humoral immunity","volume":"41","author":"Fischinger","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2019.12.041_b0090","unstructured":"Central bureau of statistics. Immigration To Israel 2017; 2018."},{"key":"10.1016\/j.vaccine.2019.12.041_b0095","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1016\/j.vaccine.2015.07.058","article-title":"Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy","volume":"33","author":"Hartal","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.041_b0100","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1017\/S0950268817002126","article-title":"Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study","volume":"145","author":"Bassal","year":"2017","journal-title":"Epidemiol Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:56Z","timestamp":1759401596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316937"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}